291 related articles for article (PubMed ID: 24674692)
21. Adenosine A2A receptor activation reduces brain metastasis via SDF-1/CXCR4 axis and protecting blood-brain barrier.
Chen L; Li L; Zhou C; Chen X; Cao Y
Mol Carcinog; 2020 Apr; 59(4):390-398. PubMed ID: 32037613
[TBL] [Abstract][Full Text] [Related]
22.
Lee TH; Lin GY; Yang MH; Tyan YC; Lee CH
Int J Med Sci; 2021; 18(13):2835-2841. PubMed ID: 34220311
[TBL] [Abstract][Full Text] [Related]
23. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D Regulates CXCL12/CXCR4 and Epithelial-to-Mesenchymal Transition in a Model of Breast Cancer Metastasis to Lung.
Li J; Luco AL; Camirand A; St-Arnaud R; Kremer R
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33693593
[TBL] [Abstract][Full Text] [Related]
25. The role of metabotropic glutamate receptor 5 on the stromal cell-derived factor-1/CXCR4 system in oral cancer.
Kuribayashi N; Uchida D; Kinouchi M; Takamaru N; Tamatani T; Nagai H; Miyamoto Y
PLoS One; 2013; 8(11):e80773. PubMed ID: 24236200
[TBL] [Abstract][Full Text] [Related]
26. CXCL12-γ in primary tumors drives breast cancer metastasis.
Ray P; Stacer AC; Fenner J; Cavnar SP; Meguiar K; Brown M; Luker KE; Luker GD
Oncogene; 2015 Apr; 34(16):2043-51. PubMed ID: 24909174
[TBL] [Abstract][Full Text] [Related]
27. [Effect of stromal cell-derived factor-1 and its receptor CXCR4 on liver metastasis of human colon cancer].
Ding YL; Fu QY; Tang SF; Zhang JL; Li ZY; Li ZT
Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):210-3. PubMed ID: 19563077
[TBL] [Abstract][Full Text] [Related]
28. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?
Hirbe AC; Morgan EA; Weilbaecher KN
Curr Pharm Des; 2010; 16(11):1284-90. PubMed ID: 20166978
[TBL] [Abstract][Full Text] [Related]
29. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
[TBL] [Abstract][Full Text] [Related]
30. Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases.
Gil M; Seshadri M; Komorowski MP; Abrams SI; Kozbor D
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):E1291-300. PubMed ID: 23509246
[TBL] [Abstract][Full Text] [Related]
31. ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling.
Masuda T; Endo M; Yamamoto Y; Odagiri H; Kadomatsu T; Nakamura T; Tanoue H; Ito H; Yugami M; Miyata K; Morinaga J; Horiguchi H; Motokawa I; Terada K; Morioka MS; Manabe I; Iwase H; Mizuta H; Oike Y
Sci Rep; 2015 Mar; 5():9170. PubMed ID: 25773070
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.
Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D
Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072
[TBL] [Abstract][Full Text] [Related]
33. Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.
Movila A; Ishii T; Albassam A; Wisitrasameewong W; Howait M; Yamaguchi T; Ruiz-Torruella M; Bahammam L; Nishimura K; Van Dyke T; Kawai T
J Bone Miner Res; 2016 Sep; 31(9):1688-700. PubMed ID: 27082509
[TBL] [Abstract][Full Text] [Related]
34. Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells.
Tang CH; Chuang JY; Fong YC; Maa MC; Way TD; Hung CH
Carcinogenesis; 2008 Aug; 29(8):1483-92. PubMed ID: 18310089
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis.
Ma WF; Du J; Fu LP; Fang R; Chen HY; Cai SH
Mol Cancer Res; 2009 Oct; 7(10):1613-21. PubMed ID: 19825996
[TBL] [Abstract][Full Text] [Related]
36. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
37. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.
Chao CC; Chen SJ; Adamopoulos IE; Davis N; Hong K; Vu A; Kwan S; Fayadat-Dilman L; Asio A; Bowman EP
Autoimmunity; 2011 May; 44(3):243-52. PubMed ID: 20925596
[TBL] [Abstract][Full Text] [Related]
38. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
Zeelenberg IS; Ruuls-Van Stalle L; Roos E
Cancer Res; 2003 Jul; 63(13):3833-9. PubMed ID: 12839981
[TBL] [Abstract][Full Text] [Related]
39. [The role of CXCR4 in lung cancer metastasis and its possible mechanism].
Su LP; Zhang JP; Xu HB; Chen J; Wang Y; Xiong SD
Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1190-4. PubMed ID: 16029594
[TBL] [Abstract][Full Text] [Related]
40. Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling.
Feys L; Descamps B; Vanhove C; Vral A; Veldeman L; Vermeulen S; De Wagter C; Bracke M; De Wever O
Oncotarget; 2015 Sep; 6(29):26615-32. PubMed ID: 26396176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]